Siemens Receives CE Mark for Whole-Body Molecular MR System

Siemens HealthcareSiemens Healthcare announced CE marking for its Biograph mMR system. The CE marking states that the product is assessed before being placed on the market and meets EU safety, clinical benefit and environmental protection requirements. Customers can begin using the new system in Europe for clinical routine application. Biograph mMR is the world's only fully integrated whole-body molecular MR with simultaneous MR and PET data acquisition technology.

Biograph mMR comprises a 3-Tesla magnetic resonance (MR) scanner and an integrated positron emission tomography (PET) detection system with an architecture that performs as one and was designed for uncompromised MR and PET image quality. While MR provides exquisite morphological and functional details in human tissue, PET goes further to investigate at the same time the human body at the level of cellular activity and metabolism. With its simultaneous data acquisition, the innovative system is expected to prove to be particularly valuable in the identification of neurological, oncological and cardiac conditions of disease and in supporting therapy planning. The Biograph mMR also opens new opportunities for research, such as the development of new biomarkers or new therapeutic approaches. Siemens has already installed a number of Biograph mMR systems at customer sites for clinical research, including university hospital Klinikum rechts der Isar of the Munich Technical University, the university hospital of the Eberhard Karls University Tuebingen in Germany, and Massachusetts General Hospital in Boston, USA.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...